Literature DB >> 17666571

Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo.

Sanchita Bhatnagar1, Kazuhiko Shinagawa, Francis J Castellino, Jeffrey S Schorey.   

Abstract

Intracellular pathogens and the molecules they express have limited contact with the immune system. Here, we show that macrophages infected with intracellular pathogens Mycobacterium tuberculosis, M bovis BCG, Salmonella typhimurium, or Toxoplasma gondii release from cells small vesicles known as exosomes which contain pathogen-associated molecular patterns (PAMPs). These exosomes, when exposed to uninfected macrophages, stimulate a proinflammatory response in a Toll-like receptor- and myeloid differentiation factor 88-dependent manner. Further, exosomes isolated from the bronchoalveolar lavage fluid (BALF) of M bovis BCG-infected mice contain the mycobacteria components lipoarabinomannan and the 19-kDa lipoprotein and can stimulate TNF-alpha production in naive macrophages. Moreover, exosomes isolated from M bovis BCG- and M tuberculosis-infected macrophages, when injected intranasally into mice, stimulate TNF-alpha and IL-12 production as well as neutrophil and macrophage recruitment in the lung. These studies identify a previously unknown function for exosomes in promoting intercellular communication during an immune response to intracellular pathogens, and we hypothesize that extracellular release of exosomes containing PAMPs is an important mechanism of immune surveillance.

Entities:  

Mesh:

Year:  2007        PMID: 17666571      PMCID: PMC2200902          DOI: 10.1182/blood-2007-03-079152

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii.

Authors:  Hana Golding; Julio Aliberti; Lisa R King; Jody Manischewitz; John Andersen; Jesus Valenzuela; Nathaniel R Landau; Alan Sher
Journal:  Blood       Date:  2003-07-10       Impact factor: 22.113

2.  Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid.

Authors:  C Admyre; J Grunewald; J Thyberg; S Gripenbäck; G Tornling; A Eklund; A Scheynius; S Gabrielsson
Journal:  Eur Respir J       Date:  2003-10       Impact factor: 16.671

3.  Macrophage surface expression of annexins I and II in the phagocytosis of apoptotic lymphocytes.

Authors:  Xiaoxuan Fan; Stephen Krahling; Douglas Smith; Patrick Williamson; Robert A Schlegel
Journal:  Mol Biol Cell       Date:  2004-04-02       Impact factor: 4.138

Review 4.  Exosomes for cancer immunotherapy.

Authors:  F Andre; B Escudier; E Angevin; T Tursz; L Zitvogel
Journal:  Ann Oncol       Date:  2004       Impact factor: 32.976

5.  The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2.

Authors:  Adam J Gehring; Roxana E Rojas; David H Canaday; David L Lakey; Clifford V Harding; W Henry Boom
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

6.  Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.

Authors:  Ulrich E Schaible; Florian Winau; Peter A Sieling; Karsten Fischer; Helen L Collins; Kristine Hagens; Robert L Modlin; Volker Brinkmann; Stefan H E Kaufmann
Journal:  Nat Med       Date:  2003-07-20       Impact factor: 53.440

7.  Identification and macrophage-activating activity of glycolipids released from intracellular Mycobacterium bovis BCG.

Authors:  E Rhoades; F- F Hsu; J B Torrelles; J Turk; D Chatterjee; D G Russell
Journal:  Mol Microbiol       Date:  2003-05       Impact factor: 3.501

8.  Mycobacterium's arrest of phagosome maturation in macrophages requires Rab5 activity and accessibility to iron.

Authors:  Victoria A Kelley; Jeffrey S Schorey
Journal:  Mol Biol Cell       Date:  2003-05-18       Impact factor: 4.138

9.  Salmonella enterica serovar Typhimurium requires nonsterol precursors of the cholesterol biosynthetic pathway for intracellular proliferation.

Authors:  Drew M Catron; Yvonne Lange; Jayme Borensztajn; Matthew D Sylvester; Bradley D Jones; Kasturi Haldar
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

Review 10.  Exosomes for immunotherapy of cancer.

Authors:  Nathalie Chaput; N E C Schartz; Fabrice Andre; Laurence Zitvogel
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

View more
  281 in total

1.  Rv2468c, a novel Mycobacterium tuberculosis protein that costimulates human CD4+ T cells through VLA-5.

Authors:  Qing Li; Xuedong Ding; Jeremy J Thomas; Clifford V Harding; Nicole D Pecora; Assem G Ziady; Samuel Shank; W Henry Boom; Christina L Lancioni; Roxana E Rojas
Journal:  J Leukoc Biol       Date:  2011-12-07       Impact factor: 4.962

Review 2.  Exosomes: immune properties and potential clinical implementations.

Authors:  Nathalie Chaput; Clotilde Théry
Journal:  Semin Immunopathol       Date:  2010-12-21       Impact factor: 9.623

3.  Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo.

Authors:  Prachi P Singh; Victoria L Smith; Petros C Karakousis; Jeffery S Schorey
Journal:  J Immunol       Date:  2012-06-20       Impact factor: 5.422

4.  Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2.

Authors:  Christina L Lancioni; Qing Li; Jeremy J Thomas; XueDong Ding; Bonnie Thiel; Michael G Drage; Nicole D Pecora; Assem G Ziady; Samuel Shank; Clifford V Harding; W Henry Boom; Roxana E Rojas
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

Review 5.  Exosomes or microvesicles? Two kinds of extracellular vesicles with different routes to modify protozoan-host cell interaction.

Authors:  Ingrid Evans-Osses; Luis H Reichembach; Marcel I Ramirez
Journal:  Parasitol Res       Date:  2015-08-15       Impact factor: 2.289

Review 6.  Using exosomes, naturally-equipped nanocarriers, for drug delivery.

Authors:  Elena V Batrakova; Myung Soo Kim
Journal:  J Control Release       Date:  2015-08-01       Impact factor: 9.776

Review 7.  Tumor-derived exosomes in oncogenic reprogramming and cancer progression.

Authors:  Sarmad N Saleem; Asim B Abdel-Mageed
Journal:  Cell Mol Life Sci       Date:  2014-08-26       Impact factor: 9.261

8.  M cell-derived vesicles suggest a unique pathway for trans-epithelial antigen delivery.

Authors:  Olivia S Sakhon; Brittany Ross; Veronica Gusti; An Joseph Pham; Kathy Vu; David D Lo
Journal:  Tissue Barriers       Date:  2015-04-03

9.  Exosomes-associated neurodegeneration and progression of Parkinson's disease.

Authors:  Isabella Russo; Luigi Bubacco; Elisa Greggio
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

10.  Short term statin treatment improves survival and differentially regulates macrophage-mediated responses to Staphylococcus aureus.

Authors:  Erin M Burns; Lisa K Smelser; Jenny E Then; Traci E Stankiewicz; Michael Kushdilian; Susan A McDowell; Heather A Bruns
Journal:  Curr Pharm Biotechnol       Date:  2013       Impact factor: 2.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.